DEF 14A

Company

AEON Biopharma, Inc.

Filed

December 29, 2025

Period of Report

December 29, 2025

Accession Number

0001837607-25-000104

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →